C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients.
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms C-control
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 18 Apr 2009 Actual end date changed from Aug 2007 to Jan 2008 as reported by ClinicalTrials.gov.
- 24 Jun 2008 New trial record.